Ruffolo Salvatore C, Forsell Pontus K A, Yuan Xiling, Desmarais Sylvie, Himms-Hagen Jean, Cromlish Wanda, Wong Kenny K, Kennedy Brian P
Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe-Claire-Dorval, Quebec, H9R 4P8, Canada.
J Biol Chem. 2007 Oct 19;282(42):30423-33. doi: 10.1074/jbc.M700697200. Epub 2007 Jul 30.
Although protein-tyrosine phosphatase 1B (PTP-1B) is a negative regulator of insulin action, adipose tissue from PTP-1B-/- mice does not show enhanced insulin-stimulated insulin receptor phosphorylation. Investigation of glucose uptake in isolated adipocytes revealed that the adipocytes from PTP-1B-/- mice have a significantly attenuated insulin response as compared with PTP-1B+/+ adipocytes. This insulin resistance manifests in PTP-1B-/- animals older than 16 weeks of age and could be partially rescued by adenoviral expression of PTP-1B in null adipocytes. Examination of adipose signaling pathways found that the basal p70S6K activity was at least 50% higher in adipose from PTP-1B-/- mice compared with wild type animals. The increased basal activity of p70S6K in PTP-1B-/- adipose correlated with decreases in IR substrate-1 protein levels and insulin-stimulated Akt/protein kinase B activity, explaining the decrease in insulin sensitivity even as insulin receptor phosphorylation was unaffected. The insulin resistance of the of the PTP-1B-/- adipocytes could also be rescued by treatment with rapamycin, suggesting that in adipose the loss of PTP-1B results in basal activation of mTOR (mammalian target of rapamycin) complex 1 leading to a tissue-specific insulin resistance.
尽管蛋白酪氨酸磷酸酶1B(PTP - 1B)是胰岛素作用的负调节因子,但来自PTP - 1B基因敲除小鼠的脂肪组织并未显示出胰岛素刺激的胰岛素受体磷酸化增强。对分离的脂肪细胞葡萄糖摄取的研究表明,与PTP - 1B基因野生型脂肪细胞相比,PTP - 1B基因敲除小鼠的脂肪细胞对胰岛素的反应明显减弱。这种胰岛素抵抗在16周龄以上的PTP - 1B基因敲除动物中表现出来,并且可以通过在缺失PTP - 1B的脂肪细胞中腺病毒表达PTP - 1B来部分挽救。对脂肪信号通路的检查发现,与野生型动物相比,PTP - 1B基因敲除小鼠脂肪组织中基础p70S6K活性至少高50%。PTP - 1B基因敲除小鼠脂肪组织中p70S6K基础活性的增加与胰岛素受体底物-1蛋白水平的降低以及胰岛素刺激的Akt/蛋白激酶B活性的降低相关,这解释了即使胰岛素受体磷酸化未受影响,胰岛素敏感性仍会降低的原因。PTP - 1B基因敲除脂肪细胞的胰岛素抵抗也可以通过雷帕霉素治疗来挽救,这表明在脂肪组织中,PTP - 1B的缺失导致雷帕霉素哺乳动物靶标(mTOR)复合物1的基础激活,从而导致组织特异性胰岛素抵抗。